Viewing nowRosuvastatin Calcium 5 mg (Rocsta Tablets)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.

MFDS item code 202005179 · Approved 2020.07.18 · Insurance code 670304530
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct for dietary and exercise management in primary hypercholesterolemia and mixed dyslipidemia when these measures are insufficient. It helps lower total cholesterol and LDL cholesterol levels, particularly in patients with familial hypercholesterolemia, thus slowing down the progression of atherosclerosis. It may also be used in pediatric patients aged 10 to 17 years who meet certain criteria to improve lipid levels. This drug is also utilized as an adjunct to diet for patients with primary dysbetalipoproteinemia. In patients at risk for cardiovascular diseases, it also aids in reducing the risk of stroke, myocardial infarction, and vascular reconstruction. Therefore, it is effectively used to alleviate hypercholesterolemia and the risks of cardiovascular diseases.
Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia: The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams once daily. Elderly: No dose adjustment is required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medication to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medication is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: The safety and efficacy in children under 10 years of age have not been established.
This medication should not be used in certain patients. For example, it is contraindicated in patients with allergies to any component of this drug, severe liver dysfunction, muscular disorders, significantly reduced kidney function, and pregnant or breastfeeding women. Additionally, this medication can potentially cause muscular issues, so it must be used with caution in patients with risk factors for myalgia or myopathy. If significant muscle pain occurs or if muscle enzyme levels rise significantly, the drug should be stopped immediately and a doctor consulted. Regular liver function tests should also be performed to monitor for any abnormalities. Patients with a history of significant alcohol consumption or liver disease require particular caution. This medication may interact with other drugs, so patients taking other medications must inform their healthcare provider. Co-administration with certain medications may increase the concentration of this drug, raising the risk of side effects. Women who may become pregnant should use appropriate contraception and must not take this medication while pregnant. Breastfeeding women should also avoid taking this medication. In cases of overdose, there is no specific antidote, so symptomatic treatment should be administered, and liver function and muscle enzyme levels should be monitored. During treatment, dizziness may occur, so caution is required when driving or operating machinery. Lastly, this medication contains lactose, so patients with lactose intolerance should not take it.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the drug's effectiveness and safety.
Yellow round film-coated tablets
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.